Medtronic, Inc.announced the acquisition of InfluENT Medical’s Repose GAHM product line for the treatment of obstructive sleep apnea (OSA). The acquisition expands Medtronic’s Surgical Technologies business unit portfolio of treatments for sleep-disordered breathing.
Medtronic, Inc.announced the acquisition of InfluENT Medical’s Repose GAHM product line for the treatment of obstructive sleep apnea (OSA). The acquisition expands Medtronic’s Surgical Technologies business unit portfolio of treatments for sleep-disordered breathing.
The Repose Genioglossus Advancement and Hyoid Advancement (GAHA) surgical devices advance the base of the tongue and the hyoid bone to prevent obstructions of the airway during sleep. In addition to the Repose System, the Surgical Technologies business of Medtronic offers the Pillar® Palatal Implant System, used to treat the soft palate component of sleep breathing disorders, and an existing family of market-leading ENT instruments used to treat other upper airway obstructions.
Bob Blankemeyer, president of the Surgical Technologies business and senior vice president at Medtronic said, he Repose GAHM devices provide our surgeon customers with another minimally invasive, low morbidity option to treat patients suffering from OSA.